Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection



Status:Active, not recruiting
Conditions:Skin Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:11/4/2018
Start Date:October 2009
End Date:October 2019

Use our guide to learn which trials are right for you!

Measuring Real Time Decision-Making About UVR Protection

The purpose of this study is to understand how people make decisions about sun protection.
This study is important in helping to protect against sun exposure, since it is a main risk
factor for melanoma. The investigators would like to understand the decisions people make
about sun protection so that they can improve their ability to help individuals who may be at
risk for melanoma.


Inclusion Criteria:

- A first-degree biological relative (a child, sibling or parent) as per self report of
an MSKCC follow-up surgical patient diagnosed with melanoma as per pathology report or
clinician's judgment;

- English-fluent; the surveys were designed and validated in English and are not
currently available in other languages. Translation of questionnaires into other
languages would require reestablishing the reliability and validity of these measures.
Therefore, participants must be able to communicate in English to complete the
surveys.

- 18 years of age or older;

- For Phase I only: FDRs who live within a 50 mile radius of MSKCC to make it feasible
for Ms. Shuk to be able to arrive at each person's home for the in-home interview
without the cost being prohibitive;

- For Phase I only: Can recall a period when s/he was out in the sun for at least one
hour on a sunny day this past summer 2009.

- For Phase I only: Can recall a separate period when s/he was out in the sun for at
least one hour on a sunny day this past summer 2009, but s/he was in a different
location from the period referenced above.

- For Phase II only: FDRs who self-report at least 1 consecutive hour in the morning
(dawn to 12:30pm) and 1 consecutive hour in the afternoon (12:30-5pm) of daily
(weekend and weekday) outdoor activities on the screening questionnaire

Exclusion Criteria:

- First-degree relatives of melanoma patients who report never using UVR protection;

- Patient's who provide consent for Phase I will not be eligible for Phase II.

- Any first-degree relative of a melanoma patient who already has a first-degree
relative who consented to the study;

- Unable to provide informed consent.
We found this trial at
1
site
1275 York Ave
New York, New York 10021
(212) 639-2000
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials